• The global Interventional Oncology Device market was valued at US$ 3.36 billion in 2023 and is projected to reach US$ 5.57 billion by 2030, at a CAGR of 7.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
• Interventional Oncology Device refers to theOncology, like internal medicine, surgery, obstetrics and gynecology, and pediatrics, is a secondary discipline of clinical medicine. It is divided into oncology, oncology radiotherapy, and oncology surgery. Oncology is mainly engaged in medical treatment of various benign and malignant tumors; The Department of Radiation Oncology is mainly engaged in radiotherapy of tumors; oncology surgery provides surgery-based comprehensive treatment. Relevant departments of specialized cancer hospitals will be subdivided according to different parts, such as gastrointestinal oncology and lymphoma oncology in the oncology department; tumor surgery includes breast surgery, head and neck surgery, thoracic surgery, tumor gynecology, and abdominal surgery.
Email:
Types
Ablation Devices
Embolization Devices
Supporting Devices • Next Generation Devices
